LIPOCINE INCORPORATED
Live / Registered — Registered and renewed (as of 28 Jul 2023)
What this means for you
Registered since 28 Jan 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Jan 2023).
Record
- Serial number
- 76017967
- Registration number
- 2681616
- Mark type
- Design + words
- Filed
- 05 Apr 2000
- Published for opposition
- 26 Dec 2000
- Registered
- 28 Jan 2003
- Next maintenance due
- 28 Jan 2023
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceutical preparations and carriers for pharmaceutically active drugs
Owner
- Lipocine, Inc., Salt Lake City, UT, US
- Lipocine, Inc., Salt Lake City, UT, US
- Lipocine, Inc., Salt Lake City, UT, US
Prosecution history
- 28 Jul 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 28 Jul 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 28 Jul 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 28 Jul 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jan 2023 — TEAS SECTION 8 & 9 RECEIVED
- 28 Jan 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Feb 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Jan 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Dec 2015 — REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
- 18 Dec 2015 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 14 Jul 2014 — REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
- 11 Jul 2014 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 11 Feb 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
- 11 Feb 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 11 Feb 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED